Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dexcom Inc DXCM

Healthcare Medical Devices
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design... see more

Recent & Breaking News (NDAQ:DXCM)

Dexcom Reports First Quarter 2024 Financial Results

Business Wire April 25, 2024

Dexcom Publishes Annual Sustainability Report

Business Wire April 3, 2024

Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time

Business Wire April 2, 2024

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

Business Wire March 5, 2024

Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD

Business Wire March 5, 2024

Dexcom Announces Upcoming Conference Presentation

Business Wire February 27, 2024

Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Business Wire February 8, 2024

Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time

Business Wire January 23, 2024

Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland

Business Wire January 19, 2024

A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2

Business Wire January 15, 2024

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook

Business Wire January 8, 2024

Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference

Business Wire December 19, 2023

Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump

Business Wire December 6, 2023

Dexcom Announces Upcoming Conference Presentation

Business Wire November 21, 2023

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

Business Wire November 14, 2023

Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don't Understand the Benefits1-2

Business Wire November 8, 2023

Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program

Business Wire October 26, 2023

Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada

Business Wire October 5, 2023

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD

Business Wire October 2, 2023

Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.

Business Wire September 29, 2023